Abstract:Purpose: Penicillins are a potent antibiotic in managing odontogenic infections, but 10% of the population is labelled as allergic to these drugs. This has limited their use and resulted in increased utilization of health care resources as well as complications associated with alternative antibiotics. The purpose of the study was to measure the association between patients labeled as penicillin allergic and treatment outcomes in a sample of patients treated for complicated odontogenic infections. Additionally, we sought to investigate antibiotic resistance patterns in these patients. Materials and methods: A retrospective cohort study was performed at the Michigan Medicine health care system to include patients who were treated for complicated odontogenic infections by oral and maxillofacial surgery between 2016 and 2020. Complicated odontogenic infection was defined as any odontogenic infection requiring admission and surgical management in the operating room. The primary predictor variable was the penicillin allergy label, which was determined by chart review and not confirmed with formal testing. Outcomes were measures of disease severity. The primary outcome variable was hospital length of stay. Secondary outcome variables were ICU admission (yes/no), repeat computed tomography scan(s), repeat surgery (yes/no), and re-admission (yes/no). Co-variates included were age, sex (male/female), tobacco use status, diabetes, immunocompromised state, number of spaces involved, white blood cell count upon admission and insurance status. For our secondary aim, the primary predictor variable was again penicillin allergy and outcome variable was antibiotic resistance as determined by wound culture results following surgical intervention. Negative binomial regression and logistic regression analyses were performed. P < .05 was considered significant. Results: A total of 150 patients met the inclusion criteria and of those 17.3% reported as penicillin allergic. Patients labelled as penicillin allergic did not differ significantly from patients without penicillin allergy label in terms of treatment outcomes. Age, diabetes, and immunosuppression were associated with an increased length of stay. Patients labelled as penicillin allergic were at significantly higher risk for antibiotic resistance (relative risk = 2.34; 95% confidence interval, 1.66 to 3.32; P < .001), specifically clindamycin resistance (relative risk = 3.17; 95% confidence interval, 1.93 to 5.18; P < .001). Conclusions: Penicillin allergy was significantly associated with clindamycin resistance. There were similar outcomes amongst patients with and without a penicillin allergy label despite antibiotic differences. Delabeling efforts for patients with a reported penicillin allergy must be considered and local nomograms for antibiotic selection should be used by providers when seeking alternative antibiotics.

Introduction of a penicillin allergy de-labelling program with direct oral challenge and its effects on utilization of beta-lactam antimicrobials: a multicenter retrospective parallel cohort study

Resource utilization and cost assessment of a proactive penicillin allergy de-labeling program for low-risk inpatients

Promoting penicillin allergy de‐labeling for children attending a hematology clinic

The challenge of de‐labeling penicillin allergy

Rising to the Challenge: An ID Provider–Led Initiative to Address Penicillin Allergy Labels at a Large Veterans Affairs Medical Center

A Multicentre Observational Study to Investigate Feasibility of a Direct Oral Penicillin Challenge in De-labelling 'Low Risk' Patients with Penicillin Allergy by Non-Allergy Healthcare Professionals (SPACE study) - implications for healthcare systems

Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge

Safe Penicillin Allergy Delabeling in Primary Care: A Systematic Review and Meta-Analysis

Factors influencing implementation and adoption of direct oral penicillin challenge for allergy delabelling: a qualitative evaluation

Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy Network

Patient Perceptions of Penicillin Allergy Testing in a Public Health System

Improving inpatient paediatric de-labelling of allergies to beta-lactams: a quality improvement study

Retrospective study on penicillin allergy delabeling and evaluation of an antibiotic allergy assessment tool

Impacts of risk-stratified inpatient penicillin allergy label delabeling on subsequent antimicrobial spectrum index and costs

Comparative Performance of 4 Penicillin-Allergy Prediction Strategies in a Large Cohort

Penicillin allergy delabeling has a significant impact on subsequent antibiotic use in primary care

1332. Single Dose Oral Amoxicillin Challenge is a Safe and Effective Strategy to Delabel Penicillin Allergies among Low Risk Hospitalized Children

The appropriateness of penicillin allergy de-labelling by non-allergist clinical ward teams

Does thePenicillin Allergy Label Affect Outcomes of Complicated Odontogenic Infections?

Effectiveness, barriers and facilitating factors of strategies for active delabelling of patients with penicillin allergy labels: a systematic review protocol

Effectiveness and feasibility of a penicillin allergy delabeling program in the postacute inpatient rehabilitation setting